Methylphenidate Treatment and Risk of Psychotic Disorder

JAMA Psychiatry. 2026 Mar 25. doi: 10.1001/jamapsychiatry.2026.0152. Online ahead of print.ABSTRACTIMPORTANCE: Methylphenidate is the leading pharmacological treatment for attention-deficit/hyperactivity disorder (ADHD) in childhood and adolescence. Individuals with ADHD have a higher risk of psycho

C Colm Healy

Unilateral Renal Denervation for Refractory Hypertension in Aortic Dissection

JACC Case Rep. 2026 Mar 25:107611. doi: 10.1016/j.jaccas.2026.107611. Online ahead of print.ABSTRACTBACKGROUD: Refractory hypertension in patients with aortic dissection represents an extreme therapeutic challenge, as these patients are typically excluded from renal denervation (RDN) trials due to p

X Xian-Geng Hou

Redefining Primary Aldosteronism

No abstractJ Am Coll Cardiol. 2026 Mar 25:S0735-1097(26)05558-0. doi: 10.1016/j.jacc.2026.02.5090. Online ahead of print.NO ABSTRACTPMID:41879587 | DOI:10.1016/j.jacc.2026.02.5090

A Anand Vaidya